Digital Therapeutics Research, Case Studies and Evaluations.
Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial
Trooper Study (MMH-R01) published in BMJ Open on 17 July 2017
- Portsmouth Hospitals NHS Trust, Portsmouth, UK
- my mhealth Ltd Bournemouth, UK
- Imperial College, London, UK
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
First publication of complete results shows a 6-week programme of online supported pulmonary rehabilitation (PR) was non-inferior to a conventional model delivered in face-to-face sessions. This study was a non-inferiority randomised control trial to compare the outcomes of an online PR programme versus conventional face to face PR, in improving physical performance and symptoms in patients with chronic obstructive pulmonary disease (COPD).
This study was a two-arm parallel single-blind, randomised controlled trial, the online arm used the online PR programme to perform PR in their own homes and the face to face arm, received conventional face to face rehabilitation in a local facility.
90 patients referred for PR, with a confirmed diagnosis of COPD and a modified Medical Research Council (MRC) score of 2 or greater were enrolled into the study. Patients were randomised, in a 2:1 ratio to receive online PR using myCOPD and 26 received conventional face to face PR. The main outcomes measured were 6-minute walk distance test and the COPD assessment test (CAT) score at completion of the programme.
The 6-week programme of online supported PR was non-inferior to a conventional model delivered in face-to-face sessions in terms of impact on the 6-minute walk test distance and symptom scores, and was safe and well tolerated by patients.
Read the full paper on bmj.com
